TNF and Behcet disease: Similarly, in 74 Behçet syndrome patients treated with anti-TNFα therapy, they found that the GA genotype was more frequent among non-responders, while the GG genotype predominated in responders, suggesting a possible role of rs1800629 as a predictive biomarker of treatment response (19).